For these patients, a GLP-1 receptor agonist is a superior, evidence-based choice over adding prandial insulin due to its targeted mechanism, weight loss benefits, and proven MACE reduction
For instance, Kim S, et al
Im glad Definitely curved my appetite (5 stars for that) BUT when my vile got low, I couldnt get the rest of the medication out so I feel I didnt get my moneys worth and it wasnt cheap Im down 13lbs in 3 weeks
In 2019, 47.2 percent of such patients had behavioural health services, but in 2024, only 12.4 percent of patients did, a relative decrease of 73.7 percent
Localized site discoloration at high-dose repeated injection Sparse community reports describe faint bluish or brownish discoloration at sites injected repeatedly with high-dose GHK-Cu (above community-typical doses)
GLP-1 drugs research timeline Weight loss drugs show promise for treating alcohol addiction Weight loss drugs effective but confer no benefit to quality of life GLP-1 drugs linked to lower long-term risk of knee replacement Appetite suppressant drugs show promise for treating addiction Stopping weight loss jabs leads to faster weight regain than after diets Drug found to be effective at treating early-onset type 2 diabetes Weight loss drug could ward off diabetes in at-risk patients
